Literature DB >> 9864744

Motor speech impairment following traumatic brain injury in childhood: a physiological and perceptual analysis of one case.

D G Theodoros1, N Shrapnel, B E Murdoch.   

Abstract

The physiological and perceptual characteristics of persistent dysarthria exhibited by a 14 year-old boy, following a severe traumatic brain injury (TBI) were investigated. The subject's speech and motor speech mechanism were comprehensively evaluated both perceptually and physiologically, and the findings were compared with those of a non-neurologically impaired control subject, matched for age and sex, and a number of control groups from previous studies. Overall, the assessments indicated that the major motor speech deficits demonstrated by the subject included severely reduced tongue function, and moderately impaired lip, laryngeal, and velopharyngeal function. Respiratory function was found to be mildly impaired. Perceptual assessments indicated that the subject's speech was severely impaired in relation to rate, pitch variation, and consonant precision, with a moderate impairment in overall intelligibility. The effects of a severe TBI on the functioning of the child's motor speech mechanism were discussed. The clinical implications for the assessment and treatment of dysarthria in childhood following severe TBI were highlighted.

Entities:  

Mesh:

Year:  1998        PMID: 9864744     DOI: 10.3109/17518429809057422

Source DB:  PubMed          Journal:  Pediatr Rehabil        ISSN: 1363-8491


  1 in total

1.  HOE-140, an antagonist of B2 receptor, protects against memory deficits and brain damage induced by moderate lateral fluid percussion injury in mice.

Authors:  Ana Paula Oliveira Ferreira; Fernanda Silva Rodrigues; Iuri Domingues Della-Pace; Bibiana Castagna Mota; Sara Marchesan Oliveira; Camila de Campos Velho Gewehr; Franciane Bobinski; Clarissa Vasconcelos de Oliveira; Juliana Sperotto Brum; Mauro Schneider Oliveira; Ana Flavia Furian; Claudio Severo Lombardo de Barros; Adair Roberto Soares dos Santos; Juliano Ferreira; Michele Rechia Fighera; Luiz Fernando Freire Royes
Journal:  Psychopharmacology (Berl)       Date:  2013-11-08       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.